Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 287
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05656248 | Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms | ||
| NCT03555955 | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 | ||
| NCT00713817 | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain | ||
| NCT04421456 | Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment | ||
| NCT03335267 | Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia | ||
| NCT04485104 | Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | ||
| NCT03904251 | CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT04943952 | JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase | ||
| NCT01606202 | A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury | ||
| NCT02150928 | An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) | ||
| NCT05557045 | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 | ||
| NCT02224703 | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome | ||
| NCT02073474 | An Observational Post-Marketing Safety Registry of Sativex® | ||
| NCT01361607 | Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer | ||
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | ||
| NCT04899947 | Child and Adolescent Registry for Participants With Narcolepsy | ||
| NCT05024552 | Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML | ||
| NCT04899050 | Epidiolex in Typical Absence Seizures | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT01604265 | A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis | ||
| NCT07290985 | AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas | ||
| NCT02596997 | Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease | ||
| NCT00702468 | Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT03825796 | CPX-351 Plus Enasidenib for Relapsed AML | ||
| NCT02806908 | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy | ||
| NCT02167685 | The Chimerix CMX001 Registry | ||
| NCT05580562 | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | ||
| NCT02053272 | A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes | ||
| NCT01610713 | An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis | ||
| NCT02269579 | Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment | ||
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | ||
| NCT04894591 | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) | ||
| NCT02647190 | Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older | ||
| NCT01606176 | A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin | ||
| NCT04803786 | A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy | ||
| NCT01265810 | Caphosol in Oral Mucositis Due to Targeted Therapy | ||
| NCT00681538 | A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) | ||
| NCT01217112 | GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes | ||
| NCT01322139 | Sativex Thorough QT/QTc Study | ||
| NCT05636111 | Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer | ||
| NCT03929666 | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | ||
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | ||
| NCT00590915 | Erwinase Master Treatment Protocol | ||
| NCT00498485 | Use of Xyrem to Improve Sleep in Chronic Fatigue Syndrome | ||
| NCT00793598 | CMX001 in Post-transplant Patients With BK Virus Viruria | ||
| NCT07153055 | Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer | ||
| NCT04006925 | Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate | ||
| NCT01322464 | Study to Assess Food Effect on Sativex Bioavailability | ||
| NCT02660255 | Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy | ||
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients |
